Format

Send to

Choose Destination
  • Filters activated: Field: Title Word. Clear all
Zhonghua Nan Ke Xue. 2013 Jun;19(6):487-94.

[Impact of NF-kappaB inhibitor on STAT3 translocation in PC-3 prostate cancer cell line].

[Article in Chinese]

Author information

1
Department of Oncology, The 10th Peoples Hospital Affiliated to Tongji University, Shanghai 200072, China. lichunyan0205@hotmail.com

Abstract

OBJECTIVE:

To observe the changes in the expressions of STAT3 and NF-KB in PC-3 cells after IL-6 stimulation and to verify the effects of the NF-KB inhibitor caffeic acid phenethyl ester (CAPE) on the expressions of p-STAT3 and IL-6 in the PC-3 prostate cancer cell line.

METHODS:

PC-3 prostate cancer cells were treated with IL-6 at 20 ng/ml for 5, 10, 20, 30 and 45 min. The protein and mRNA expressions of STAT3 and NF-kappaB were measured by Western blot and real time PCR, respectively, and the cell cycle was detected by flow cytometry. The PC-3 cells were exposed to TNF-alpha or TNF-alpha + CAPE, followed by determination of the IL-6 expression in the supernatant of the cells by ELISA and the expression of p-STAT3 by Western blot.

RESULTS:

After IL-6 stimulation, both the expression of p-STAT3 protein and the proliferation index of the PC-3 cells were significantly increased, and so were the expressions of IL-6 and p-STAT3 protein in the supernatant after TNF-alpha treatment (P < 0.05). TNF-alpha + CAPE induced statistically lower expressions of IL-6 and p-STAT3 than TNF-alpha alone (P < 0.05).

CONCLUSION:

CAPE can inhibit IL-6 secretion induced by TNF-alpha in PC-3 cells and thus suppress STAT3 translocation. Therefore, by inhibiting the expression of NF-kappaB and affecting STAT3 and other related cell signaling pathways, CAPE may become a new therapeutic option for prostate cancer.

PMID:
23862224
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center